CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing and New LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results

COLA is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. Below are links to the most recent messages on additional CMS guidance on SARS-CoV-2 laboratory testing and the new LOINC In-Vitro Diagnostic (LIVD) test code mapping for SARS-CoV-2 test results.

CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing

New LOINC In-Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results